TLR4 signalling repertoire is involved in a variety of liver injury including that induced by NASH, which has been shown to play a key role during fibrogenesis in preclinical models of NAFLD (37), as wells as to enhance TGF-β signalling (38). The gene discussed is TLR4; the disease is metabolic dysfunction-associated steatotic liver disease.